We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$2.6B
AUM Growth
+$88.6M
Cap. Flow
+$182M
Cap. Flow %
7%
Top 10 Hldgs %
5.43%
Holding
2,448
New
367
Increased
862
Reduced
666
Closed
534

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$24.6M
2
VTRS icon
Viatris
VTRS
+$17.9M
3
ORCL icon
Oracle
ORCL
+$15.1M
4
CAH icon
Cardinal Health
CAH
+$12.5M
5
LOW icon
Lowe's Companies
LOW
+$11.1M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$10.2M
2
MO icon
Altria Group
MO
+$9.53M
3
LRCX icon
Lam Research
LRCX
+$8.47M
4
MSFT icon
Microsoft
MSFT
+$8.3M
5
FDX icon
FedEx
FDX
+$8.02M

Sector Composition

Rank Sector Weight
1 Healthcare 16.78%
2 Technology 15.81%
3 Consumer Discretionary 13.36%
4 Industrials 11.28%
5 Financials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JBSS icon
176
John B. Sanfilippo & Son
JBSS
$954M
$3.03M 0.12%
58,401
-10,281
-15% -$515K
PENN icon
177
PENN Entertainment
PENN
$2.75B
$3.03M 0.12%
165,118
-12,627
-7% -$210K
WFM
178
DELISTED
Whole Foods Market Inc
WFM
$3M 0.12%
76,204
-80,178
-51% -$3.59M
AMRI
179
DELISTED
Albany Molecular Research Inc
AMRI
$2.99M 0.11%
147,955
+34,383
+30% +$664K
SVU
180
DELISTED
SUPERVALU Inc.
SVU
$2.99M 0.11%
52,737
+8,580
+19% +$572K
ROST icon
181
Ross Stores
ROST
$81B
$2.93M 0.11%
60,203
+16,249
+37% +$817K
JUNO
182
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.92M 0.11%
+54,700
New +$2.9M
DYAX
183
DELISTED
DYAX CORPORATION
DYAX
$2.92M 0.11%
109,989
+52,789
+92% +$1.4M
PEP icon
184
PepsiCo
PEP
$191B
$2.9M 0.11%
31,068
+18,020
+138% +$1.72M
TPR icon
185
Tapestry
TPR
$30.8B
$2.9M 0.11%
83,783
+37,757
+82% +$1.44M
CTSH icon
186
Cognizant
CTSH
$24.3B
$2.87M 0.11%
47,040
+27,237
+138% +$1.71M
AGN
187
DELISTED
Allergan plc
AGN
$2.86M 0.11%
9,416
-14,741
-61% -$4.4M
PTCT icon
188
PTC Therapeutics
PTCT
$6.26B
$2.85M 0.11%
59,274
+35,385
+148% +$2.06M
IDT icon
189
IDT Corp
IDT
$1.64B
$2.85M 0.11%
223,067
-586
-0.3% -$7.43K
SNBR
190
DELISTED
Sleep Number
SNBR
$2.85M 0.11%
94,614
+27,968
+42% +$885K
AZO icon
191
AutoZone
AZO
$49.1B
$2.83M 0.11%
4,250
+3,020
+246% +$2.07M
DNY
192
DELISTED
DONNELLEY R R & SONS CO
DNY
$2.82M 0.11%
161,591
+40,349
+33% +$703K
HBIO icon
193
Harvard Bioscience
HBIO
$27.5M
$2.81M 0.11%
49,288
+19,781
+67% +$1.13M
CY
194
DELISTED
Cypress Semiconductor
CY
$2.8M 0.11%
237,736
+85,162
+56% +$1.12M
DLX icon
195
Deluxe
DLX
$1.19B
$2.79M 0.11%
45,083
+2,444
+6% +$161K
CYH icon
196
Community Health Systems
CYH
$391M
$2.78M 0.11%
53,361
+10,669
+25% +$479K
CST
197
DELISTED
CST Brands, Inc.
CST
$2.77M 0.11%
70,824
+38,501
+119% +$1.6M
IPG
198
DELISTED
Interpublic Group of Companies
IPG
$2.75M 0.11%
142,785
+93,014
+187% +$1.93M
CBK
199
DELISTED
Christopher & Banks Corporation
CBK
$2.74M 0.11%
684,267
+326,341
+91% +$1.79M
CELG
200
DELISTED
Celgene Corp
CELG
$2.74M 0.11%
23,707
-26,395
-53% -$3.02M
6 7
8
9 10

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return

GSA Capital Partners's Q2 2015 Portfolio in Review

As of Q2 2015, GSA Capital Partners held 2,448 positions worth $2.6B, up 3.5% from $2.52B the previous quarter. Its ten largest holdings account for 5.4% of the portfolio.

GSA Capital Partners deployed $182M of net new capital in Q2 2015, opening 367 new positions and adding to 862 existing holdings. Its largest new stake was Halliburton: 200,972 shares worth $8.66M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Illumina, an estimated $10.2M trimmed.

  • GSA Capital Partners's largest Q2 2015 buy was Halliburton: 200,972 shares worth $8.66M.
  • GSA Capital Partners added most to Micron Technology in Q2 2015, an estimated $24.6M increase.
  • GSA Capital Partners's biggest Q2 2015 reduction was Illumina, cutting an estimated $10.2M.
  • GSA Capital Partners fully exited Altria Group in Q2 2015, selling an estimated $9.53M.
  • GSA Capital Partners's ten largest holdings make up 5.4% of its $2.6B portfolio in Q2 2015.
  • GSA Capital Partners opened 367 new positions and closed 534 in Q2 2015.
  • GSA Capital Partners's portfolio value rose 3.5% quarter-over-quarter to $2.6B.

Based on GSA Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.